| Washington University at St. Louis |
Photoacoustic tomography with and without biomarkers |
Sentinel lymph node imaging and guided needle biopsy, early prediction of chemotherapy response, breast cancer screening |
In vivo studies in comparison to existing clinical standards |
| |
|
|
|
| The University of Texas Health Science Center—Houston |
Near-infrared fluorescence imaging with biomarkers |
Lymphedema treatment assessment, non-invasive sentinel and cancerous lymph node identification, surgery guidance |
New probes toxicity and batch release, cost/effectiveness |
| |
|
|
|
| Stanford University |
Visible/near-infrared fluorescence imaging with biomarkers |
Detection of inflammation, premalignancies and cancer, stratifications of tumors for COX-2 expression |
Demonstration of clinical efficacy |
| |
|
|
|
| The University of Michigan |
Endoscopic multispectral fluorescence imaging with biomarkers |
Early detection of colorectal cancer using specific peptides to target flat and depressed lesions |
In vivo peptide specificity and toxicity |
